Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1981 2
1983 1
1991 1
1998 1
2000 2
2001 2
2002 2
2003 3
2004 3
2005 4
2006 8
2007 11
2008 11
2009 12
2010 4
2011 7
2012 9
2013 8
2014 9
2015 11
2016 10
2017 12
2018 13
2019 22
2020 24
2021 12
2022 10
2023 10
2024 9
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Using sertraline in postpartum and breastfeeding: balancing risks and benefits.
Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, Beccarini Crescenzi B, Bolognesi S, Goracci A, Coluccia A, Ferretti F, Fagiolini A. Cuomo A, et al. Among authors: coluccia a. Expert Opin Drug Saf. 2018 Jul;17(7):719-725. doi: 10.1080/14740338.2018.1491546. Epub 2018 Jul 5. Expert Opin Drug Saf. 2018. PMID: 29927667 Review.
New potent EV-A71 antivirals targeting capsid.
Roux H, Touret F, Coluccia A, Khoumeri O, Di Giorgio C, Majdi C, Sciò P, Silvestri R, Vanelle P, Roche M. Roux H, et al. Among authors: coluccia a. Eur J Med Chem. 2024 Oct 5;276:116658. doi: 10.1016/j.ejmech.2024.116658. Epub 2024 Jul 7. Eur J Med Chem. 2024. PMID: 39088999
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability.
Puxeddu M, Ling L, Ripa S, D'Ambrosio M, Nalli M, Parisi A, Sciò P, Coluccia A, Granese A, Santelli M, Masci D, Cuřínová P, Naro C, Sette C, Pastore A, Stornaiuolo M, Bigogno C, Dondio G, Di Magno L, Canettieri G, Liu T, Silvestri R, La Regina G. Puxeddu M, et al. Among authors: coluccia a. J Med Chem. 2024 Nov 28;67(22):20298-20314. doi: 10.1021/acs.jmedchem.4c01708. Epub 2024 Nov 7. J Med Chem. 2024. PMID: 39508273
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses.
Sciò P, Scoffone VC, Parisi A, Bufano M, Caneva M, Trespidi G, Irudal S, Barbieri G, Cariani L, Orena BS, Daccò V, Imperi F, Buroni S, Coluccia A. Sciò P, et al. Among authors: coluccia a. ACS Infect Dis. 2025 Apr 11;11(4):998-1007. doi: 10.1021/acsinfecdis.4c01045. Epub 2025 Mar 18. ACS Infect Dis. 2025. PMID: 40100965 Free PMC article.
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor.
Coluccia A, Bufano M, La Regina G, Puxeddu M, Toto A, Paone A, Bouzidi A, Musto G, Badolati N, Orlando V, Biagioni S, Masci D, Cantatore C, Cirilli R, Cutruzzolà F, Gianni S, Stornaiuolo M, Silvestri R. Coluccia A, et al. Cancers (Basel). 2022 Mar 7;14(5):1358. doi: 10.3390/cancers14051358. Cancers (Basel). 2022. PMID: 35267666 Free PMC article.
223 results